Delivery Order 75N92020D00022-75N92E25F50002

Award Date 2/24/25
Potential Completion Date 4/24/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute, a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the supply of an INFINIUM GLOBAL DIVERSITY ARRAY-8 V1.0 KIT (96 SAMPLES), with a ceiling value of $54,704.93 and a performance period through March 27, 2025. There is no set-aside designation for this award. Illumina has a history of providing sequencing...
This is a $15,629.98 firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. for the INFINIUM GLOBAL DIVERSITY ARRAY-8 V1.0 KIT (96 SAMPLES). The order has a completion date of November 7, 2024. Illumina is a manufacturer and provider of genomic sequencing and analysis instruments and reagents. The company has a history of providing a range of sequencing systems, consumables, and...
This is a federal contract award from the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the procurement of 48-sample INFINIUM GLOBAL DIVERSITY ARRAY-8 V1.0 KIT, a genomic analysis product, with a ceiling value of $36,043.06. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an...
This is a firm fixed-price delivery order contract awarded by the National Institute on Aging, a Civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing and array-based analysis equipment and reagents. The contract, valued at $69,572.16, is for the delivery of Illumina's Infinium Global Diversity Array-8+ V1.0 Kits, which are laboratory supplies used for genetic analysis. This award is not associated with a set-aside program. Illumina has previously received prime federal...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute, part of the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The order is for two units of the INFINIUM QC ARRAY-24 V1.0 KIT (48 SAMPLES) at $1,197.90 each, totaling $2,395.80. The award has a ceiling value of $19,241.96 and a period of performance through September 30, 2024. Illumina has a history of...
This is a federal delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of an INFINIUM QC ARRAY-24 V1.0 KIT (288 SAMPLES), with a firm fixed price of $28,532.40 and a period of performance through March 31, 2025. The contract was awarded on September 3, 2020 and does not have a set-aside designation. Illumina, a manufacturer of sequencing and...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis instruments and reagents. The order is for 16 samples of the Infinium Omni5Exome-4 v1.3 BeadChip, a genomic analysis product, with a ceiling value of $19,903.32. The order has a period of performance through March 31, 2025. This award is under a broader federal contract vehicle that Illumina holds,...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of 9 units of the INFINIUM HUMANOMNIEXPRESS V1.1 DNA ANALYSIS KIT, 48 SAMPLES at a total ceiling value of $118,994.65. The award was made on a non-set-aside basis. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has received prior prime...
Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and reagents, was awarded a $146,645.78 firm fixed price delivery order contract by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The contract is for the provision of 24 INFINIUM EXOME-24 V1.1 KIT (48 SAMPLES) units at a unit price of $2,272.50, with a completion date of September 2, 2025. The contract does not have a set-aside designation. Illumina has...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $490,033.00 and supports the provision of Illumina's sequencing and array-based solutions for genetic and genomic analysis to NHGRI. The contract does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and genomics analysis instruments and reagents, and...
  • 75N92020D00022
    Indefinite Delivery Contract
  • 75N92020D00022-75N92E25F50002
    Delivery Order

This is a firm-fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Illumina, Inc. for the INFINIUM GLOBAL DIVERSITY ARRAY-8 V1.0 KIT (48 SAMPLES). The contract has a ceiling value of $19,535.20 and is set to be completed by April 24, 2025. Illumina is a manufacturer of DNA sequencing and genomic analysis instruments and reagents, and has previously received other prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to support their genomics research and diagnostic efforts. This order does not have a set-aside designation.

Generated 2/21/25, 9:04 AM